Instrument Inactif

Communiqués INSMED Nasdaq

Actions

US4576692085

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Communiqués

04/09/13	INSMED : to Participate in the Stifel Healthcare Conference 2013	PU
07/08/13	INSMED : to Participate in August Investor Conferences	PU
06/08/13	INSMED : Reports Second Quarter Financial Results	PU
31/07/13	INSMED : to Host Second Quarter 2013 Financial Results Conference Call on Tuesday, August 6, 2013	PU
29/07/13	INSMED : Appoints Christine Pellizzari as General Counsel and Corporate Secretary	PU
22/07/13	INSMED : Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares	PU
17/07/13	INSMED : Announces Pricing of Public Offering of Common Stock	PU
15/07/13	INSMED : Announces Proposed Public Offering of Common Stock	PU
08/07/13	INSMED : to Present at the 8th Annual JMP Securities Healthcare Conference	PU
01/07/13	INSMED : ARIKACE Meets Primary Endpoint of Non-Inferiority to TOBI in Phase 3 Clinical Trial in Europe and Canada to Treat Pseudomonas aeruginosa in Cystic Fibrosis Patients	PU
29/06/13	INSMED : to Report Top-Line Results From Phase 3 Clinical Trial of ARIKACE to Treat Pseudomonas Aeruginosa in Cystic Fibrosis	PU
28/06/13	INSMED : to Join the Russell Global(R) and Russell 3000(R) Indexes	PU
14/05/13	INSMED : Granted Key Composition of Matter Patent Allowance for ARIKACE in Europe	PU
13/05/13	INSMED : to Present at the UBS Global Healthcare Conference	PU
10/05/13	INSMED : to Present at the Bank of America Merrill Lynch 2013 Health Care Conference	PU
07/05/13	INSMED : Reports First Quarter Financial Results	PU
01/05/13	INSMED : to Host First Quarter 2013 Financial Results Conference Call on Tuesday, May 7, 2013	PU
18/04/13	INSMED : to Present at the 12th Annual Needham Healthcare Conference	PU
01/04/13	INSMED : Appoints Matthew Pauls as Chief Commercial Officer	PU
28/03/13	INSMED : ARIKACE Receives Orphan Drug Designation for Treating Infections Caused by Non-Tuberculous Mycobacteria	PU
18/03/13	INSMED : Reports Fourth Quarter and Full Year 2012 Financial Results	PU
11/03/13	INSMED : to Host Fourth Quarter and Full Year 2012 Financial Results Conference Call on Monday, March 18, 2013	PU
26/02/13	INSMED : to Present at Two Upcoming Investor Conferences	PU
06/02/13	INSMED : to Present at Two Upcoming Healthcare Investor Conferences	PU
16/05/12	INSMED : Appoints Donald J. Hayden, Jr. as Executive Chairman	PU